| Primary |
| Drug Use For Unknown Indication |
45.1% |
| Acne |
36.0% |
| Product Used For Unknown Indication |
7.0% |
| Contraception |
4.2% |
| Acne Cystic |
2.2% |
| Neuroblastoma |
1.2% |
| Glioblastoma Multiforme |
0.4% |
| Asthma |
0.4% |
| Oral Contraception |
0.4% |
| Brain Stem Glioma |
0.4% |
| Anaemia |
0.3% |
| Malignant Melanoma |
0.3% |
| Acne Conglobata |
0.3% |
| Pregnancy |
0.3% |
| Depression |
0.3% |
| Bipolar Disorder |
0.2% |
| Keratosis Follicular |
0.2% |
| Medulloblastoma |
0.2% |
| Pain |
0.2% |
| Psoriasis |
0.2% |
|
| Pregnancy |
52.2% |
| Abortion Induced |
9.1% |
| Suicidal Ideation |
5.3% |
| Rectal Haemorrhage |
4.2% |
| Drug Exposure During Pregnancy |
3.3% |
| Treatment Noncompliance |
3.1% |
| No Adverse Event |
2.5% |
| Suicide Attempt |
2.4% |
| Normal Newborn |
2.4% |
| Abortion Spontaneous |
2.2% |
| Death |
1.9% |
| Surgery |
1.8% |
| Completed Suicide |
1.4% |
| Exposure During Pregnancy |
1.4% |
| Unintended Pregnancy |
1.4% |
| Vaginal Haemorrhage |
1.3% |
| Vomiting |
1.3% |
| Sacroiliitis |
1.2% |
| Live Birth |
1.0% |
| Off Label Use |
0.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
42.1% |
| Acne |
24.6% |
| Product Used For Unknown Indication |
7.1% |
| Contraception |
5.0% |
| Medulloblastoma |
4.2% |
| Anaemia |
3.7% |
| Acne Cystic |
2.1% |
| Keratosis Follicular |
1.8% |
| Neuroblastoma |
1.4% |
| Glioblastoma Multiforme |
1.2% |
| Oral Contraception |
0.8% |
| Depression |
0.8% |
| Primitive Neuroectodermal Tumour |
0.8% |
| Asthma |
0.7% |
| Psoriasis |
0.7% |
| Anxiety |
0.7% |
| Neoplasm |
0.7% |
| Pain |
0.6% |
| Bipolar Disorder |
0.5% |
| Chemotherapy |
0.5% |
|
| Pregnancy |
60.4% |
| Suicidal Ideation |
5.6% |
| Treatment Noncompliance |
4.2% |
| Abortion Induced |
3.6% |
| Normal Newborn |
3.6% |
| Suicide Attempt |
3.2% |
| Unintended Pregnancy |
2.3% |
| Urinary Tract Infection |
2.3% |
| Pallor |
1.6% |
| Off Label Use |
1.4% |
| Sinusitis |
1.4% |
| White Blood Cell Count Decreased |
1.4% |
| Wisdom Teeth Removal |
1.4% |
| Lip Dry |
1.3% |
| Vomiting In Pregnancy |
1.3% |
| Abortion Spontaneous |
1.1% |
| Acute Myeloid Leukaemia |
1.0% |
| Cardiovascular Disorder |
1.0% |
| Inflammatory Bowel Disease |
1.0% |
| Live Birth |
1.0% |
|
| Concomitant |
| Acne |
31.0% |
| Product Used For Unknown Indication |
17.7% |
| Medulloblastoma |
8.6% |
| Contraception |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| Suicide Attempt |
3.4% |
| Depression |
3.0% |
| Multiple Sclerosis |
3.0% |
| Pain |
3.0% |
| Body Height Below Normal |
2.6% |
| Renal Hypertension |
2.6% |
| Acne Conglobata |
2.2% |
| Acne Cystic |
2.2% |
| Neuroblastoma |
2.2% |
| Premenstrual Syndrome |
2.2% |
| Ankylosing Spondylitis |
1.7% |
| Bipolar Disorder |
1.7% |
| Bone Disorder |
1.7% |
| Congestive Cardiomyopathy |
1.7% |
| Hyperphosphataemia |
1.7% |
|
| Pulmonary Embolism |
10.3% |
| Acne Fulminans |
8.6% |
| Unintended Pregnancy |
8.6% |
| Bone Pain |
5.2% |
| Depression |
5.2% |
| Glomerulonephropathy |
5.2% |
| Lung Infection |
5.2% |
| Stillbirth |
5.2% |
| Vomiting |
5.2% |
| Withdrawal Syndrome |
5.2% |
| Xerosis |
5.2% |
| Cough |
3.4% |
| Drug Ineffective |
3.4% |
| Dyspepsia |
3.4% |
| Fatigue |
3.4% |
| Leukopenia |
3.4% |
| Myalgia |
3.4% |
| Neck Pain |
3.4% |
| No Adverse Effect |
3.4% |
| Pneumonitis |
3.4% |
|
| Interacting |
| Neuroblastoma |
38.1% |
| Acne |
23.8% |
| Epilepsy |
9.5% |
| Ankylosing Spondylitis |
4.8% |
| Contraception |
4.8% |
| Depression |
4.8% |
| Localised Infection |
4.8% |
| Malignant Melanoma |
4.8% |
| Prophylaxis |
4.8% |
|
| Epilepsy |
22.2% |
| Tibia Fracture |
22.2% |
| Disturbance In Attention |
11.1% |
| Drug Interaction |
11.1% |
| Eyelid Oedema |
11.1% |
| Lip Dry |
11.1% |
| Pregnancy On Oral Contraceptive |
11.1% |
|
